JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Down 19.7% in January

Posted by Jared Coughlin on Feb 17th, 2025

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report) saw a significant decrease in short interest in January. As of January 31st, there was short interest totalling 338,200 shares, a decrease of 19.7% from the January 15th total of 421,200 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

JCR Pharmaceuticals Price Performance

JCRRF remained flat at $4.57 during trading on Monday. The business has a fifty day simple moving average of $4.57 and a two-hundred day simple moving average of $4.54. JCR Pharmaceuticals has a 12 month low of $4.30 and a 12 month high of $4.70.

JCR Pharmaceuticals Company Profile

(Get Free Report)

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.